Intro

This chapter explores the issues leading to the failure of MDMA-assisted psychotherapy for PTSD, including boundary violations and functional unblinding. It discusses the recent FDA panel's rejection of the therapy, clinical trial challenges, and the potential influence of therapists on patient outcomes.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.